COLIN OTTEY: Open Payments
NPI 1649453101 · LANHAM, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$414 in 11 payments from 9 companies in 2025. Trend: 2023 $102 · 2024 $119 · 2025 $414
Food & beverage: $414
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $242 |
| PFIZER INC. | 1 | $52 |
| Exact Sciences Corporation | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Novo Nordisk Inc | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Amgen Inc. | 1 | $15 |
| Dexcom, Inc. | 1 | $14 |
Products named: Yeztugo, Epclusa, Cologuard Collection Kit, GARDASIL 9, Wegovy, SHINGRIX, REPATHA, Dexcom G6 Transmitter.
Industry payments across MD — which companies pay providers there.
